245 related articles for article (PubMed ID: 15230036)
1. [Pathophysiological evolution of coronary (ischemic) heart disease: ischemia, dystrophy, necrosis, sclerosis].
Zakharov VN
Klin Med (Mosk); 2004; 82(5):25-7. PubMed ID: 15230036
[TBL] [Abstract][Full Text] [Related]
2. [Acute focal dystrophy of the myocardium with hibernating or stunned myocardium].
Zakharov VN
Klin Med (Mosk); 2002; 80(6):67-70. PubMed ID: 12138809
[TBL] [Abstract][Full Text] [Related]
3. [Current views on stunned and hibernating myocardium].
Simon K; Czuriga I
Orv Hetil; 2003 Dec; 144(50):2465-9. PubMed ID: 15067985
[TBL] [Abstract][Full Text] [Related]
4. Myocardial hibernation.
Heusch G; Schulz R
Ital Heart J; 2002 May; 3(5):282-4. PubMed ID: 12066558
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of the hibernating myocardium in early stages of heart failure in patients with coronary heart disease].
Fomina IG; Georgadze ZA; Gaĭdamakina NE; Galanina NA
Klin Med (Mosk); 2000; 78(4):24-7. PubMed ID: 10833885
[TBL] [Abstract][Full Text] [Related]
6. [The heart and ischemia: stunned-hibernating myocardium].
Wutte M; Maurer G
Wien Klin Wochenschr; 1997; 109 Suppl 1():25-33. PubMed ID: 9173671
[No Abstract] [Full Text] [Related]
7. [Hibernation and stunning as manifestations of ischemic dysfunction of the myocardium].
Sokolova RI; Zhdanov VS
Kardiologiia; 2005; 45(9):73-8. PubMed ID: 16234797
[TBL] [Abstract][Full Text] [Related]
8. Adaptation of nonrevascularized human hibernating and chronically stunned myocardium to long-term chronic myocardial ischemia.
Wiggers H; Nielsen SS; Holdgaard P; Flø C; Nørrelund H; Halbirk M; Nielsen TT; Egeblad H; Rehling M; Bøtker HE
Am J Cardiol; 2006 Dec; 98(12):1574-80. PubMed ID: 17145213
[TBL] [Abstract][Full Text] [Related]
9. Assessment of myocardial viability: review of the clinical significance.
Ramos M; DePasquale E; Coplan NL
Rev Cardiovasc Med; 2008; 9(4):225-31. PubMed ID: 19122580
[TBL] [Abstract][Full Text] [Related]
10. Characterization of hibernating myocardium with NOGA electroanatomic endocardial mapping.
Gyöngyösi M; Khorsand A; Sochor H; Sperker W; Strehblow C; Graf S; Binder T; Glogar D
Am J Cardiol; 2005 Mar; 95(6):722-8. PubMed ID: 15757597
[TBL] [Abstract][Full Text] [Related]
11. Myocardial viability--mechanisms of reversible myocardial dysfunction and diagnosis in coronary artery disease.
Goldberg L; Mekel J; Landless P; Smith D; Grigorov V
Cardiovasc J S Afr; 2001; 12(3):169-75. PubMed ID: 11533740
[TBL] [Abstract][Full Text] [Related]
12. Myocardial stunning: an experimental act with a large clinical audience.
Heyndrickx GR
Arch Mal Coeur Vaiss; 2003 Jun; 96(6):665-70. PubMed ID: 12868349
[TBL] [Abstract][Full Text] [Related]
13. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
14. [Hibernation and stunning as manifestations of ischemic dysfunction of the myocardium].
Sokolova RI; Zhdanov VS
Arkh Patol; 2002; 64(1):50-4. PubMed ID: 11889704
[TBL] [Abstract][Full Text] [Related]
15. Reversible myocardial dysfunction: basics and evaluation.
Gowda RM; Khan IA; Vasavada BC; Sacchi TJ
Int J Cardiol; 2004 Dec; 97(3):349-53. PubMed ID: 15561318
[TBL] [Abstract][Full Text] [Related]
16. Multifocal ischemic necroses of varying age (MINOVA): A distinctive form of atherosclerotic heart disease.
Taube JM; Hutchins GM
Pathol Res Pract; 2008; 204(2):113-20. PubMed ID: 17931791
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of cell survival in myocardial hibernation.
Depre C; Vatner SF
Trends Cardiovasc Med; 2005 Apr; 15(3):101-10. PubMed ID: 16039970
[TBL] [Abstract][Full Text] [Related]
18. Should patients with type 2 diabetes asymptomatic for coronary artery disease undergo testing for myocardial ischemia?
O'Rourke RA
Nat Clin Pract Cardiovasc Med; 2005 Oct; 2(10):492-3. PubMed ID: 16186827
[No Abstract] [Full Text] [Related]
19. [Update on ischemic heart disease].
Fernández-Ortiz A; Jiménez-Candil J; Bodí V; Barrabés JA
Rev Esp Cardiol (Engl Ed); 2012 Jan; 65 Suppl 1():42-9. PubMed ID: 22269839
[TBL] [Abstract][Full Text] [Related]
20. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
